{"abstract": "The $41 billion tie-up announced last week between Merck and Schering-Plough creates some interesting options for Johnson & Johnson. ", "web_url": "https://dealbook.nytimes.com/2009/03/16/diagnosing-jjs-next-move/", "snippet": "", "lead_paragraph": "The $41 billion tie-up announced last week between Merck and Schering-Plough creates some interesting options for Johnson & Johnson. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Diagnosing J.&J.\u2019s Next Move", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-03-16T16:41:21+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/90c56ba0-256f-555f-90d0-e0dc3124de3a", "word_count": 1346, "uri": "nyt://article/90c56ba0-256f-555f-90d0-e0dc3124de3a"}